New

Stem-cell programme for Type 2 diabetes in Boao Lecheng — 2026 guide

← All treatments

CAR-T & Cell Therapy

Cellular programmes that can be verified today.

Status
Routine / NMPA-approved
Destination
China
Authorising body
National Medical Products Administration
Public reference
NMPA registered indication
Last checked
· from published sources

What “Routine / NMPA-approved” means

Registered with the National Medical Products Administration and available through normal hospital admission. The registration number is on the treatment page.

How we verify, and what each date means →

Already been advised to seek treatment abroad?

If a physician has advised treatment and you need hospital review and coordination arranged, that is what we do. We do not diagnose, treat, or make eligibility decisions.

Start with a short description of the situation. Please do not send passport scans, payment details, or your full medical records in a first message — we will tell you exactly what is needed, and when.

Check my options

MedAccess.care coordinates access and does not diagnose, treat, or decide eligibility. Every treatment has different evidence, regulatory status, risks, and eligibility requirements. Final treatment decisions are made by participating hospitals and their licensed physicians.